Results 191 to 200 of about 283,343 (354)
Objective We evaluated serious infection risk in offspring exposed to tumor necrosis factor inhibitors (TNFi) in utero, separated by TNFi timing and placental transfer ability. Methods Using MarketScan (2011–2021), we identified offspring born to mothers with chronic inflammatory diseases.
Leah K. Flatman +6 more
wiley +1 more source
P26.05.B DOSE-DEPENDENT DISTRIBUTION OF METHOTREXATE IN THE JUVENILE PIG BRAIN FOLLOWING INTRAVENOUS HIGH-DOSE METHOTREXATE INFUSION [PDF]
Torben Valdbjørn Rasmussen +7 more
openalex +1 more source
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin +15 more
wiley +1 more source
Efficacy and safety of non-conventional synthetic disease-modifying antirheumatic drugs in early active rheumatoid arthritis: a network meta-analysis. [PDF]
Xu H +12 more
europepmc +1 more source
Objective Antiphospholipid syndrome (APS) is a thrombo‐inflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)‐positive patients using whole‐blood transcriptomics.
Amala Ambati +13 more
wiley +1 more source
Cost-Effectiveness Analysis of Recombinant Tumor Necrosis Factor Receptor: Fc Fusion Protein as First-Line Treatment for Active Rheumatoid Arthritis in China. [PDF]
Zhang R, Ma A.
europepmc +1 more source
Successful conservative management with methotrexate and mifepristone of cervical pregnancy
Eliza Shrestha +3 more
openalex +2 more sources

